Biotech stocks are in focus as analysts track upcoming clinical data and regulatory decisions in autoimmune and rare disease ...

Sanofi's amlitelimab has shown promise in the Phase III COAST 1 trial, but data from the COAST 2 study is yet to be announced ...

Rapport Therapeutics, Inc., a clinical-stage biotechnology company focused on developing precision medicines for neurological and psychiatric disorders, is hosting its first Investor and Analyst Day ...

For as long as I’ve worked in data and analytics, predictions of disappearing roles have been common. A decade ago, it was the data warehouse developer. Then it was the data steward. Today, some say ...